{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T18:52:37Z","timestamp":1775847157470,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pmed.1005040","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000}}],"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["757699"],"award-info":[{"award-number":["757699"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["Leaving no-one behind: transforming gendered pathways to health for TB"],"award-info":[{"award-number":["Leaving no-one behind: transforming gendered pathways to health for TB"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R-202309-71190"],"award-info":[{"award-number":["R-202309-71190"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["304666\/Z\/23\/Z"],"award-info":[{"award-number":["304666\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current tuberculosis (TB) prevention and care strategies have failed to reduce disease burden at the pace required to meet global targets. Community screening may enable more rapid declines in TB burden, but evidence is limited. We used mathematical modelling to evaluate approaches using different diagnostic algorithms, population coverage, and duration of screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>We used a deterministic compartmental TB model, which recognised symptomatic and asymptomatic infectious TB (defined by whether an individual reported symptoms at screening), as well as noninfectious TB. We simulated diagnostic algorithms targeting symptomatic infectious TB (prolonged cough with confirmatory Xpert Ultra), infectious TB (Xpert Ultra), or all TB (chest X-ray), and we varied population coverage and duration of screening. Main outcomes were estimated reduction in symptomatic TB incidence and TB mortality over a 10-year horizon.<\/jats:p>\n                    <jats:p>Maximum coverage (100%) and duration (five annual rounds) was projected to reduce symptomatic TB incidence by 26.9% (UI 22.8, 31.5%) with the algorithm targeting symptomatic TB and 74.0% (UI 68.5, 79.1%) with the algorithm targeting infectious TB. However, incidence rebounded at the end of screening, erasing 9.8% and 15.9%, respectively, of those reductions within 5 years. The algorithm targeting all TB showed higher potential for rapid reductions\u2014over 98%\u2014with negligible rebound; however, low diagnostic accuracy of current tools led to prohibitive overdiagnosis, with 7.2 false positives per true positive in a single round of screening. Screening algorithms targeting broader disease definitions (infectious or all TB) generally achieved greater impact with lower population coverage and\/or duration. Findings were broadly similar for mortality.<\/jats:p>\n                    <jats:p>As a modelling study, our approach assumed a homogeneous population for simplicity and required assumptions where data were lacking around algorithm performance, treatment acceptance, and treatment completion across disease states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We show that substantial reductions in TB morbidity and mortality can be achieved by community screening, highlighting the importance of symptom-agnostic algorithms and the need to balance population coverage and duration. To maximise and sustain epidemiological impact, accurate diagnostic tools and appropriate treatment regimens for individuals with noninfectious TB are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1005040","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:31:47Z","timestamp":1775496707000},"page":"e1005040","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trade-offs in diagnostic algorithm, population coverage, and duration of community screening for tuberculosis: A modelling study"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7542-4065","authenticated-orcid":true,"given":"Katherine C.","family":"Horton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9886-8104","authenticated-orcid":true,"given":"Alexandra S.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-9719","authenticated-orcid":true,"given":"Alvaro","family":"Schwalb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-7467","authenticated-orcid":true,"given":"Rein M. G. J.","family":"Houben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"pmed.1005040.ref001","author":"World Health Organization","year":"2015"},{"key":"pmed.1005040.ref002","author":"World Health Organization","year":"2025"},{"key":"pmed.1005040.ref003","author":"World Health Organization","year":"2021"},{"issue":"1","key":"pmed.1005040.ref004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-2600(24)00372-2","article-title":"Managing tuberculosis before the onset of symptoms","volume":"13","author":"D Falzon","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"6","key":"pmed.1005040.ref005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","article-title":"Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise","volume":"12","author":"AK Coussens","year":"2024","journal-title":"Lancet Respir Med"},{"key":"pmed.1005040.ref006","author":"World Health Organization","year":"2013"},{"issue":"11","key":"pmed.1005040.ref007","first-page":"1183","article-title":"Active case finding of tuberculosis: historical perspective and future prospects","volume":"9","author":"JE Golub","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"pmed.1005040.ref008","author":"WHO Expert Committee on Tuberculosis","year":"1974"},{"issue":"5","key":"pmed.1005040.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(21)00033-5","article-title":"Community-based active case-finding interventions for tuberculosis: a systematic review","volume":"6","author":"RM Burke","year":"2021","journal-title":"Lancet Public Health"},{"issue":"1","key":"pmed.1005040.ref010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s44263-024-00042-9","article-title":"Community-based active-case finding for tuberculosis: navigating a complex minefield","volume":"2","author":"P MacPherson","year":"2024","journal-title":"BMC Glob Public Health"},{"issue":"47","key":"pmed.1005040.ref011","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221186120","article-title":"Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis","volume":"120","author":"KC Horton","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pmed.1005040.ref012","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","article-title":"Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis","volume":"171","author":"S Verver","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"pmed.1005040.ref013","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82469","article-title":"Estimating the contribution of subclinical tuberculosis disease to transmission: an individual patient data analysis from prevalence surveys","volume":"12","author":"JC Emery","year":"2023","journal-title":"Elife"},{"issue":"6","key":"pmed.1005040.ref014","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis","volume":"54","author":"JR Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"pmed.1005040.ref015","unstructured":"United Nations Department of Economic and Social Affairs. World Population Prospects 2022 2023. Available from: https:\/\/population.un.org\/wpp\/"},{"key":"pmed.1005040.ref016","author":"World Health Organization","year":"2022"},{"key":"pmed.1005040.ref017","author":"World Health Organization","year":"2022"},{"key":"pmed.1005040.ref018","article-title":"Emulation and history matching using the hmer package","author":"A Iskauskas","year":"2022","journal-title":"arXiv preprint"},{"key":"pmed.1005040.ref019","author":"World Health Organization","year":"2023"},{"issue":"2","key":"pmed.1005040.ref020","article-title":"Xpert Ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis","volume":"2","author":"JS Zifodya","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"pmed.1005040.ref021","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1824","article-title":"The spectrum of tuberculosis disease in an Urban Ugandan community and its health facilities","volume":"72","author":"EA Kendall","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pmed.1005040.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1402","article-title":"Subclinical tuberculosis disease\u2014a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology","volume":"73","author":"B Frascella","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pmed.1005040.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001272","article-title":"Accuracy of computer-aided chest X-ray in community-based tuberculosis screening: lessons from the 2016 Kenya National Tuberculosis Prevalence Survey","volume":"2","author":"B Mungai","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"9","key":"pmed.1005040.ref024","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v033.i09","article-title":"Solving differential equations in R: packagedesolve","volume":"33","author":"K Soetaert","year":"2010","journal-title":"J Stat Soft"},{"issue":"9","key":"pmed.1005040.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004278","article-title":"Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional survey (TREATS)","volume":"20","author":"E Klinkenberg","year":"2023","journal-title":"PLoS Med"},{"issue":"11","key":"pmed.1005040.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004448","article-title":"Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950\u20131963: an epidemiological analysis of historical data","volume":"21","author":"P MacPherson","year":"2024","journal-title":"PLoS Medicine"},{"issue":"8","key":"pmed.1005040.ref027","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"JJ Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pmed.1005040.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00082-7","article-title":"Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study","volume":"11","author":"AS Richards","year":"2023","journal-title":"Lancet Glob Health"},{"key":"pmed.1005040.ref029","doi-asserted-by":"crossref","first-page":"107875","DOI":"10.1016\/j.ijid.2025.107875","article-title":"Scaling-up symptom-agnostic, community-wide screening toward global tuberculosis elimination: opportunities, challenges, and lessons from history","volume":"155","author":"H Esmail","year":"2025","journal-title":"Int J Infect Dis"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1005040","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:56:24Z","timestamp":1775843784000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005040"}},"subtitle":[],"editor":[{"given":"Mia","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1005040","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]}}}